Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bernier

Showing results (471-480 of 480) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 480 results.
Stem Cells (Dayton, Ohio)|January 11, 2016
A Primitive Growth Factor, NME7AB , Is Sufficient to Induce Stable Naïve State Human Pluripotency; Reprogramming in This Novel Growth Factor Confers Superior DifferentiationM G Carter, B J Smagghe, A K Stewart, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
BMJ Open|July 30, 2025
Predicting dysglycaemia in individuals with gestational diabetes immediately postpartum using continuous glucose monitoring (PREDISPOSE) in a multicentre prospective cohort study in Canada: a study protocolSarah M Sigurdson, Katherine J Bernier, Lois E Donovan, et al.
Plos One|March 19, 2013
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve stateBenoit J Smagghe, Andrew K Stewart, Mark G Carter, et al.
British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.
Cancer Detection and Prevention|January 1, 1981
A cooperative study on the detection of colorectal cancer and polyps in FranceF Martin, T Poynard, A Ribet, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]J C Horiot, P Bontemps, A C Begg, et al.
Journal of the National Cancer Institute|January 30, 2009
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapyJ L Lefebvre, F Rolland, M Tesselaar, et al.
Frontiers in Genetics|August 17, 2019
Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva InitiativeChristoffer Nellåker, Fowzan S Alkuraya, Gareth Baynam, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)A S Allal, C Ares, P Dulguerov, et al.
Pageof 48

Showing results (471-480 of 480) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 480 results.
Stem Cells (Dayton, Ohio)|January 11, 2016
A Primitive Growth Factor, NME7AB , Is Sufficient to Induce Stable Naïve State Human Pluripotency; Reprogramming in This Novel Growth Factor Confers Superior DifferentiationM G Carter, B J Smagghe, A K Stewart, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
BMJ Open|July 30, 2025
Predicting dysglycaemia in individuals with gestational diabetes immediately postpartum using continuous glucose monitoring (PREDISPOSE) in a multicentre prospective cohort study in Canada: a study protocolSarah M Sigurdson, Katherine J Bernier, Lois E Donovan, et al.
Plos One|March 19, 2013
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve stateBenoit J Smagghe, Andrew K Stewart, Mark G Carter, et al.
British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.
Cancer Detection and Prevention|January 1, 1981
A cooperative study on the detection of colorectal cancer and polyps in FranceF Martin, T Poynard, A Ribet, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]J C Horiot, P Bontemps, A C Begg, et al.
Journal of the National Cancer Institute|January 30, 2009
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapyJ L Lefebvre, F Rolland, M Tesselaar, et al.
Frontiers in Genetics|August 17, 2019
Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva InitiativeChristoffer Nellåker, Fowzan S Alkuraya, Gareth Baynam, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)A S Allal, C Ares, P Dulguerov, et al.
Pageof 48